Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind, placebo-controlled study in adults with celiac disease is currently recruiting; Forte Biosciences is sponsoring the trial (dru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Forte Biosciences, Inc. | Conditions: Celiac Disease | Phase 2 | Status: RECRUITING